 |
|
 |
 |
 |
 |
 |
| Applied Research Preclinical Development Clinical Development I-III Degraded Samples (FFPE) Publications |
  Ultimately, Althea's biotech and pharmaceutical partners benefit from eXpress Pathway's regulated process which includes validation of biomarker signatures with disease-specific characterized samples, GLP testing, manufacturing under Good Manufacturing Practice (GMP), and commercially available adoption mechanisms that enable broad access to diagnostic tests for better disease management and targeted therapeutics. |
 |
 |
